• Sectors
    • Tech
    • Healthcare
    • Consumer
    • Energy
    • Mining & Metals
    • Business Services
    • Financials
    • Telecom
    • Industrials
    • Transportation
    • Aerospace & Defense
    • Real Estate
    • Utilities
  • Spotlight Stocks
  • CEO Interview
    • Investor Presentations
  • Newsmakers
  • Investing Strategy
    • Analyst Reports
    • Insider Trading
    • Smart Money
  • Funds & ETF’s
  • Markets
    • Commodities
    • Currencies
    • Economy
    • Lending & Interest Rates
  • Business News
    • Trading Ideas
  • Executive Resources
    • Leadership & Strategy
    • Capital
    • Law
  • Investor Education
    • Long Term Investing
    • Personal Finance
    • Stock Trading
    • Options Trading
    • Forex Trading
    • Futures Trading
  • Members
Newswire
  • [ May 24, 2019 ] China aluminum magnate Zhang Shiping dies aged 73 Business News
  • [ May 24, 2019 ] Fears of deeper U.S.-China trade war push Asian shares to four-month low Business News
  • [ May 24, 2019 ] Oil bounces back, but markets remain fragile amid trade disputes Business News
  • [ May 24, 2019 ] India’s jobs deficit: Project in Gujarat struggling to create employment Business News
  • [ May 24, 2019 ] Asian shares at four-month low on deepening U.S.-China trade war Business News
  • [ May 24, 2019 ] Exclusive: JPMorgan cuts ties with OxyContin maker Purdue Pharma – sources Business News
  • [ May 24, 2019 ] Oil prices stabilize after sharp falls earlier in week Business News
  • [ May 24, 2019 ] U.S. regulator sees approval of Boeing 737 MAX to fly as soon as late June: sources Business News
  • [ May 24, 2019 ] FAA chief calls eight-hour meeting on Boeing 737 MAX ‘exceedingly positive’ Business News
  • [ May 24, 2019 ] Trump says ‘dangerous’ Huawei could be included in U.S.-China trade deal Business News
HomeHealthcareHow to Trade Biotech and Pharmaceutical Stocks

How to Trade Biotech and Pharmaceutical Stocks

March 11, 2018 admin Healthcare, Investor Education Comments Off on How to Trade Biotech and Pharmaceutical Stocks

How to Trade Biotech and Pharmaceutical Stocks
Profiting from the FDA approval cycle

Add to my social media sites
SubscribeDiggdel.icio.usFacebookRedditStumbleUponTechnorati




Previous

Exelixis (NASDAQ: EXEL) CEO Michael Morrissey gives an update on cabozantinib

Next

Rick Rule on Gold and Contrarian Stock Picks for 2018

Featured Stocks

newsmakers

  • American Premium Water Corp. (OTC: HIPH) Announces Successful Development of CBD Infused Beer, Full Production and Distribution Scheduled
    May 23, 2019 Comments Off on American Premium Water Corp. (OTC: HIPH) Announces Successful Development of CBD Infused Beer, Full Production and Distribution Scheduled
  • CytoDyn (OTC: CYDY) Files Pivotal Trial Protocol for HIV Monotherapy with FDA
    May 20, 2019 Comments Off on CytoDyn (OTC: CYDY) Files Pivotal Trial Protocol for HIV Monotherapy with FDA
  • Nightfood (OTC: NGTF) Quarterly Report Discloses Highest Revenue Quarter to Date; Investor Call Scheduled for May 28; Updates on Ice Cream Distribution, New Product Development, Munchies
    May 20, 2019 Comments Off on Nightfood (OTC: NGTF) Quarterly Report Discloses Highest Revenue Quarter to Date; Investor Call Scheduled for May 28; Updates on Ice Cream Distribution, New Product Development, Munchies
  • GP Solutions (OTC: GWPD) Installs State-of-the-Art Growth Chamber at University of California, Riverside
    May 20, 2019 Comments Off on GP Solutions (OTC: GWPD) Installs State-of-the-Art Growth Chamber at University of California, Riverside
  • American Premium Water Corp. (OTC: HIPH) Announces Agreement with Lynne Franks to Create Line of CBD-Infused Women’s Beauty & Well Being Products to be Sold in the United Kingdom
    May 17, 2019 Comments Off on American Premium Water Corp. (OTC: HIPH) Announces Agreement with Lynne Franks to Create Line of CBD-Infused Women’s Beauty & Well Being Products to be Sold in the United Kingdom
  • Nightfood (OTC: NGTF) Quarterly Report Discloses Highest Revenue Quarter to Date; Investor Call Scheduled for May 28; Updates on Ice Cream Distribution, New Product Development, Munchies
    May 16, 2019 Comments Off on Nightfood (OTC: NGTF) Quarterly Report Discloses Highest Revenue Quarter to Date; Investor Call Scheduled for May 28; Updates on Ice Cream Distribution, New Product Development, Munchies
LEADERS

Chatham Rock Phosphate Limited (TSX.V: NZP) “Hundred Bagger” upside potential

The Yield Growth Corp. (CSE: BOSS) (OTC: BOSQF) Building brands “At the intersection of cannabis & wellness”

American Premium Water Corp (OTC: HIPH) Building CBD-infused consumer brand portfolio

GP Solutions (OTC: GWPD) Indoor organic farming tech innovation addressing billion dollar markets

NightFood Holdings, Inc. (OTC: NGTF) Is this the next Billion Dollar Brand?

CytoDyn (OTC: CYDY) Monoclonal antibody HIV treatment w potential FDA approval in 2019

Medicine Man Technologies (OTC: MDCL) Vertically integrated cannabis operator, with growing revenues and profits

Cobalt27 (TSX.V: KBLT) (OTC: CBLLF) A “pure play” on electric vehicle boom

CytoDyn Inc. (OTC: CYDY) Monoclonal antibody for treating HIV and Cancer. Potential FDA approval for HIV in 2019

Elixinol Global Limited (ASX: EXL) (OTC: ELLXF) Emerging leader in CBD and Hemp foods and consumer products

  • Contact
  • About Us
  • Investor Relations Services
  • Terms of Use/Legal Notice
  • Become a Newsmaker
  • Login
  • Newsmakers Account
    • Subscriptions
    • Submit Press Release

Copyright © 2019 | MH Magazine WordPress Theme by MH Themes